These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11237535)

  • 1. Reverse cholestrol transport substantially influences the individual risk of coronary heart disease in hypercholesterolaemic patients.
    Poledne R; Rosolová H
    Eur Heart J; 2001 Mar; 22(6):442-3. PubMed ID: 11237535
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
    Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
    Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composition of LDL particle discriminates between hypercholesterolaemic persons with and without symptoms of coronary heart disease.
    Van Jaarsveld H; Pool GF; Bester CJ
    Ann Clin Biochem; 2004 May; 41(Pt 3):213-9. PubMed ID: 15117435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The child is father of the man.
    Glueck CJ
    Pediatrics; 1986 Aug; 78(2):364-8. PubMed ID: 3526271
    [No Abstract]   [Full Text] [Related]  

  • 5. [Findings or disease--lipid metabolism with reference to the heart].
    Wolfram G
    Internist (Berl); 1986 Mar; 27(3):158-65. PubMed ID: 3519502
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipid profile in 4 minutes. Impressing your coronary heart disease patients].
    Janssen K
    MMW Fortschr Med; 2000 Jul; 142(26-27):39. PubMed ID: 10929482
    [No Abstract]   [Full Text] [Related]  

  • 7. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
    Lowry RP; Soltys G; Mangel R; Kwiterovitch P; Sniderman AD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2229-32. PubMed ID: 3547921
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of high total cholesterol with coronary heart disease mortality differs among subject populations--familial hypercholesterolemia as a key concept.
    Okuyama H; Ichikawa Y; Sun Y; Hamazaki T; Lands WE
    World Rev Nutr Diet; 2007; 96():19-36. PubMed ID: 17167278
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2.
    Gupta R; Gupta VP; Sarna M; Bhatnagar S; Thanvi J; Sharma V; Singh AK; Gupta JB; Kaul V
    Indian Heart J; 2002; 54(1):59-66. PubMed ID: 11999090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
    Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma exchange therapy in a patient with familial hypercholesteremia and generalized arteriosclerosis].
    Schrecker O; Thies K; Schlierf G
    Internist (Berl); 1984 Sep; 25(9):574-6. PubMed ID: 6386739
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New diagnostic tests for assessing coronary heart disease risk.
    Naito HK
    Prog Clin Biol Res; 1988; 255():49-62. PubMed ID: 3277204
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL testing should be routine part of assessments of coronary heart disease risk, says consensus panel.
    Clin Pharm; 1992 May; 11(5):378, 381. PubMed ID: 1582128
    [No Abstract]   [Full Text] [Related]  

  • 17. Joint effects of serum triglycerides and LDL and HDL cholesterol.
    Avins AL; Hulley SB
    Circulation; 1993 Jan; 87(1):300-1. PubMed ID: 8419022
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglycerides and coronary artery disease.
    Sum CF; Tan CE; Wang KW
    Singapore Med J; 1992 Oct; 33(5):443-5. PubMed ID: 1455264
    [No Abstract]   [Full Text] [Related]  

  • 20. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
    Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
    Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.